A double blind placebo-controlled randomized phase III study of high dose continuous infusion cytosine arabinoside (araC) with or without cloretazine (R) in patients with first relapse of acute myeloid leukemia (AML).

Rezultati

Naziv:	A double blind placebo-controlled randomized phase III study of high dose continuous infusion cytosine arabinoside (araC) with or without cloretazine (R) in patients with first relapse of acute myeloid leukemia (AML).
Autori:	Giles, Francis J; Stock, Wendy; Vey, Norbert; Sciter, Karen; DeAngelo, Daniel J; Boskovic, Darinka V; Stuart, Robert K; Johnson, Bonny; Cahill, Ann L; O'Brien, Susan
Godina:	2006
Publikacija:	BLOOD
ISSN:	0006-4971 Blood Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 108 br. 11 str. 1970-1970
DOI:	10.1182/blood.V108.11.1970.1970
WoS-ID:	000242440002488
URI:	https://enauka.gov.rs/handle/123456789/797844
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

1
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Unpaywall

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.